China has approved a new weight-loss drug that is poised to rival Novo Nordisk and Eli Lilly's popular GLP-1 treatments, ...

Danish companies will get easier access to foreign labor under a plan presented by the government that seeks to balance its ...

Novo Nordisk Foundation Challenge Programme awards DKK 479 million to nine innovative projects. These projects promote health ...

As you look at the stock markets around the world, it’s always a balance of trying to decide when is the right time to buy.

More than 20 million people globally are injecting themselves with GLP-1s... Weight-loss pills will only see that explode ...

These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.

The NNF – a philanthropic non-profit organisation that owns a controlling stake in Danish drugmaker Novo Nordisk – has been ...

Novo Nordisk Foundation Challenge Programme awards DKK 479 million to nine innovative projects that advance health and sustainabilit ...

Proteins are the workhorses of biology. They perform virtually every important function in living organisms. They store, copy and protect our DNA, digest food to give us energy, and harness this ...

Raise awareness of obesity as a chronic, multifactorial disease. Reduce stigma and myths that hinder early care. Encourage ...

Novo Nordisk is seen as having fallen behind in the race for new obesity drugs. It argues it is playing the long game.

Under the deal, cash-paying patients can access a month's supply of Wegovy through the Danish drugmaker's Novocare pharmacy ...